Sofinnova Capital VI FCPR

Sofinnova Capital VI FCPR is a declared insider at 3 companies; the most frequent names are HOOKIPA Pharma Inc., Omthera Pharmaceuticals, Inc. and BioAmber Inc. We count 26 filings; the first trade dates from 16 April 2013 and the latest from 21 April 2021.

The open-market side counts 3 purchases for €8.2M alongside 16 sales for €8.6M. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2021 alone, the filings show no purchases and 8 sales.

The record was last updated on 23 April 2021 with an open-market sale (€3.2M) in HOOKIPA Pharma Inc. The clock since the last published purchase (25 April 2019) now reads 2,739 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.